Skip to main content
. 2022 Apr 14;11(8):2196. doi: 10.3390/jcm11082196

Figure 3.

Figure 3

Plot of the relative percent difference between genders for treatments prescribed (A) and target achievement (B) in the population in primary prevention (ACEI/ARBII, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers; BP, blood pressure; CCB, calcium channel blockers; HbA1c, glycated hemoglobin; LDL-c, low-density lipoprotein cholesterol; OAD, oral antidiabetic drug).